{"PubmedArticle": [{"MedlineCitation": {"InvestigatorList": [], "SpaceFlightMission": [], "CitationSubset": ["IM"], "KeywordList": [], "GeneralNote": [], "OtherAbstract": [], "OtherID": [], "PMID": "23277522", "DateCompleted": {"Year": "2013", "Month": "06", "Day": "13"}, "DateRevised": {"Year": "2019", "Month": "12", "Day": "10"}, "Article": {"Language": ["eng"], "ELocationID": ["10.1183/09031936.00123612"], "ArticleDate": [], "Journal": {"ISSN": "1399-3003", "JournalIssue": {"Volume": "41", "Issue": "1", "PubDate": {"Year": "2013", "Month": "Jan"}}, "Title": "The European respiratory journal", "ISOAbbreviation": "Eur Respir J"}, "ArticleTitle": "The anti-IL-17A antibody secukinumab does not attenuate ozone-induced airway neutrophilia in healthy volunteers.", "Pagination": {"StartPage": "239", "EndPage": "241", "MedlinePgn": "239-41"}, "AuthorList": [{"AffiliationInfo": [], "Identifier": [], "LastName": "Kirsten", "ForeName": "Anne", "Initials": "A"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Watz", "ForeName": "Henrik", "Initials": "H"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Pedersen", "ForeName": "Frauke", "Initials": "F"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Holz", "ForeName": "Olaf", "Initials": "O"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Smith", "ForeName": "Rachel", "Initials": "R"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Bruin", "ForeName": "Gerard", "Initials": "G"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Koehne-Voss", "ForeName": "Stephan", "Initials": "S"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Magnussen", "ForeName": "Helgo", "Initials": "H"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Waltz", "ForeName": "David A", "Initials": "DA"}], "PublicationTypeList": ["Clinical Trial, Phase II", "Letter", "Randomized Controlled Trial", "Research Support, Non-U.S. Gov't"]}, "MedlineJournalInfo": {"Country": "England", "MedlineTA": "Eur Respir J", "NlmUniqueID": "8803460", "ISSNLinking": "0903-1936"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Antibodies, Monoclonal"}, {"RegistryNumber": "0", "NameOfSubstance": "Antibodies, Monoclonal, Humanized"}, {"RegistryNumber": "0", "NameOfSubstance": "Interleukin-17"}, {"RegistryNumber": "66H7ZZK23N", "NameOfSubstance": "Ozone"}, {"RegistryNumber": "DLG4EML025", "NameOfSubstance": "secukinumab"}], "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Adult"}, {"QualifierName": ["therapeutic use"], "DescriptorName": "Antibodies, Monoclonal"}, {"QualifierName": [], "DescriptorName": "Antibodies, Monoclonal, Humanized"}, {"QualifierName": [], "DescriptorName": "Double-Blind Method"}, {"QualifierName": [], "DescriptorName": "Female"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": ["immunology"], "DescriptorName": "Interleukin-17"}, {"QualifierName": ["chemically induced", "drug therapy"], "DescriptorName": "Leukocyte Disorders"}, {"QualifierName": ["chemically induced", "drug therapy"], "DescriptorName": "Lung Diseases"}, {"QualifierName": [], "DescriptorName": "Male"}, {"QualifierName": ["drug effects"], "DescriptorName": "Neutrophils"}, {"QualifierName": ["adverse effects"], "DescriptorName": "Ozone"}, {"QualifierName": [], "DescriptorName": "Time Factors"}, {"QualifierName": [], "DescriptorName": "Treatment Failure"}]}, "PubmedData": {"ReferenceList": [], "History": [{"Year": "2013", "Month": "1", "Day": "2", "Hour": "6", "Minute": "0"}, {"Year": "2013", "Month": "1", "Day": "2", "Hour": "6", "Minute": "0"}, {"Year": "2013", "Month": "6", "Day": "14", "Hour": "6", "Minute": "0"}], "PublicationStatus": "ppublish", "ArticleIdList": ["23277522", "10.1183/09031936.00123612", "41/1/239"]}}], "PubmedBookArticle": []}